{"id":"https://openalex.org/A5111042630","orcid":null,"observed_orcids":[],"display_name":"Elisabet Sanchez","raw_author_names":["ELISABET SANCHEZ","Elisabet Sanchez"],"full_name":"Elisabet Sanchez","works_count":21,"cited_by_count":943,"summary_stats":{"2yr_mean_citedness":30.4,"h_index":13,"i10_index":15},"ids":{"openalex":"https://openalex.org/A5111042630","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210104168","ror":"https://ror.org/01apxt611","display_name":"Medway NHS Foundation Trust","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]},"years":[2025,2024,2023,2022,2021]}],"last_known_institutions":[{"id":"https://openalex.org/I4210104168","ror":"https://ror.org/01apxt611","display_name":"Medway NHS Foundation Trust","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104168"]}],"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","count":6,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","count":4,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","count":4,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","count":3,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":6.75e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12587","display_name":"Gestational Trophoblastic Disease Studies","value":3.11e-05,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12793","display_name":"Caveolin-1 and cellular processes","value":2.88e-05,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","value":2.41e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12108","display_name":"Management of metastatic bone disease","value":2.38e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.976953387260437},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.6643017530441284},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.5767121315002441},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.5503376126289368},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.4563466012477875}],"counts_by_year":[{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2022,"works_count":4,"oa_works_count":4,"cited_by_count":21},{"year":2023,"works_count":11,"oa_works_count":9,"cited_by_count":136},{"year":2024,"works_count":3,"oa_works_count":3,"cited_by_count":318},{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":309},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":158}],"display_name_alternatives":["ELISABET SANCHEZ","Elisabet Sanchez"],"block_key":"e sanchez","works_api_url":"https://api.openalex.org/works?filter=author.id:A5111042630","updated_date":"2026-11-08T12:57:04","created_date":"2021-10-11T00:00:00"}